ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $413,000 | +74.3% | 98,195 | +71.0% | 0.01% | +83.3% |
| Q4 2016 | $237,000 | +99.2% | 57,429 | +289.6% | 0.01% | +100.0% |
| Q3 2016 | $119,000 | -71.9% | 14,741 | -72.9% | 0.00% | -66.7% |
| Q2 2016 | $424,000 | +90.1% | 54,305 | +88.3% | 0.01% | +50.0% |
| Q1 2016 | $223,000 | +7.7% | 28,843 | +50.5% | 0.01% | +50.0% |
| Q4 2015 | $207,000 | +6.2% | 19,170 | -32.2% | 0.00% | +33.3% |
| Q3 2015 | $195,000 | +75.7% | 28,272 | +125.1% | 0.00% | +50.0% |
| Q2 2015 | $111,000 | -62.1% | 12,558 | -57.8% | 0.00% | -66.7% |
| Q1 2015 | $293,000 | -55.6% | 29,752 | -55.0% | 0.01% | -53.8% |
| Q3 2014 | $660,000 | +441.0% | 66,155 | +77.4% | 0.01% | +550.0% |
| Q1 2014 | $122,000 | +159.6% | 37,282 | +165.4% | 0.00% | +100.0% |
| Q4 2013 | $47,000 | 0.0% | 14,050 | -10.3% | 0.00% | 0.0% |
| Q3 2013 | $47,000 | – | 15,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |